2 I insulin- komparatorkontrollerede forsøg, i hvilke metformin og sulphonylurinstof blev givet som kombinationslægemidler, var incidensen for disse bivirkninger sammenlignelig for insulin - og BYETTA- behandlede patienter.
2 In insulin-comparator controlled studies in which metformin and a sulphonylurea were concomitant medicinal products, the incidence for these adverse reactions was similar for insulin- and BYETTA- treated patients.